The diagnostic performance, as evaluated via ROC analysis, showed that L1CAM+ exosome-associated tau was modestly predictive in distinguishing between PD and healthy controls (AUC = 0.607), and was associated with disease duration but not with other clinical scales in pwPD [45]. This evidence concerns the gene MAPT and Parkinson disease.